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Tocotrienol inhibits proliferation of human
Tenon’s fibroblasts in vitro: a comparative
study with vitamin E forms and mitomycin C
Abstract Purpose: To evaluate the
potential of the vitamin E compound
α-tocotrienol as antifibrotic agent in
vitro. Methods: Using human Te-
non’s capsule fibroblast cultures, the
antiproliferative and cytotoxic effects
of the different vitamin E forms
α-tocopherol, α-tocopheryl acetate,
α-tocopheryl succinate and α-toco-
trienol were compared with those of
mitomycin C. To mimic subconjunc-
tival and regular oral application in
vivo, exposure time of serum-stimu-
lated and serum-restimulated fibro-
blasts (SF and RF, respectively) to
vitamin E forms was set at 6 days.
Cultures were only exposed for 5 min
to mitomycin C due to its known
acute toxicity and to mimic the short-
time intraoperative administration.
Proliferation (expressed as % of con-
trol) was determined by DNA content
quantification on days 2, 4 and 6,
whereas cytotoxicity was assessed by
cell morphology and glucose 6-phos-
phate dehydrogenase (G6PD) release
after 24 h. Results: α-Tocopherol
and α-tocopheryl acetate stimulated
growth of SF, but not RF. Reduction
of fibroblast content by α-tocopheryl
succinate was accompanied by in-
creased G6PD release and necrosis.
Contrary to α-tocopheryl succinate,
50 μM or repeatedly 20 μM of α-
tocotrienol significantly inhibited
proliferation without causing cellular
toxicity (maximal effect: 46.8%). RF
were more sensitive to this effect than
SF. Mitomycin C 100–400 μg/ml
showed a stronger antiproliferative
effect than α-tocotrienol (maximal
effect: 13.8%). Morphologic charac-
teristics of apoptosis were more
commonly found under treatment
with mitomycin C. Conclusions: Of
the vitamin E forms tested, only α-
tocotrienol significantly inhibited
growth at non-toxic concentrations. In
this in vitro study, antiproliferative
effects of mitomycin C were stronger
than those of α-tocotrienol.
Introduction
Failure of glaucoma filtration surgery is mostly due to
fibrosis of the surgical fistula and the filtering bleb [1, 14].
Fibroblasts from the conjunctival-Tenon’s capsule-epi-
scleral interface migrate to the surgical site, proliferate,
and secrete extracellular matrix components, ultimately
leading to excessive scar formation [14]. Unfortunately, the
antiinflammatory and antiproliferative effects of topical
steroids are often not sufficient to avoid the induction of
this process.
Mitomycin C is currently the most frequently used agent
to inhibit this cicatrisation [18, 35]. However, adjunctive
topical chemotherapy with mitomycin C is associated with
severe and potentially sight-threatening complications such
as ocular hypotony and endophthalmitis [15, 23, 26]. Cy-
totoxic effects to various cell types seem to be responsible
for these serious side effects [27, 33, 36, 42].
In the search for therapeutic alternatives we focused on
vitamin E, the most important lipid-soluble antioxidant in
the human body. Vitamin E is a generic name. Tocopherols
and tocotrienols represent the two subclasses within the
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vitamin E family of compounds, both of them consisting of
α-, β-, γ-, and δ-isoforms. Esterized forms such as α-
tocopheryl acetate or succinate also exhibit vitamin E ac-
tivity. Lipid-rich plant products and vegetable oils are the
main natural sources of vitamin E.
Vitamin E protects biological membranes from oxida-
tion by acting as a radical chain breaking molecule. Im-
portant novel neuroprotective [28], antithrombotic [48],
antiinflammatory [16], hypocholesterolemic [53], antiath-
erogenic [46], and antineoplastic effects [24, 32, 50] of
vitamin E cannot all be attributed to the antioxidant activity
alone. Increasing evidence suggests involvement of mul-
tiple intracellular signaling pathways [4, 19, 45]. It has to
be emphasized that the biological functions strongly de-
pend on the vitamin E form applied, and that not all cell
types are as susceptible to these effects.
The vitamin E forms α-tocopherol, α-tocopheryl acetate
and α-tocopheryl succinate have been previously tested in
in vitro and in animal model studies for potential appli-
cations in glaucoma filtration surgery and in the prevention
of proliferative vitreoretinopathy [10, 11, 20–22, 29, 37,
38, 40, 41]. However, results were conflicting [30], and
there is a need to compare directly the antiproliferative and
cytotoxic effects of these different vitamin E forms with
mitomycin C, the gold standard of antiscarring drugs in
glaucoma filtration surgery.
α-Tocotrienol is one of the major vitamin E compounds
in palm oil. Similar to tocopherols, the antiproliferative
effects of tocotrienols are mediated by inhibition of protein
kinase C [44]. In human and murine tumor cells, toco-
trienols induce a cell-cycle arrest in the G-1 phase and
apoptosis [54]. To the best of our knowledge, the potential
of tocotrienols as antifibrotic agents has not been evaluated.
By using human primary Tenon’s capsule fibroblast
cultures, we therefore compared the antiproliferative and
cytotoxic effects of α-tocopherol, α-tocopheryl acetate, α-
tocopheryl succinate, and α-tocotrienol with those of mito-
mycin C.
Materials and methodes
Reagents
α-Tocopherol (RRR-α-tocopherol) was obtained fromCognis
(Duesseldorf, Germany), α-tocopheryl acetate (dl-α-toco-
pherol acetate) and α-tocopheryl succinate (d-α-tocopherol
succinate) were from Supelco (distributed by Fluka Chemie,
Buchs, Switzerland). RRR-α-Tocotrienol was a kind gift
from the Malaysian Palm Oil Board (Kuala Lumpur, Ma-
laysia). Vitamin E forms were dissolved in ethanol absolute
and then stored light-protected at 4°C. Mitomycin C (Mi-
tomycin-C Kyowa) was purchased from Kyowa (distrib-
uted by Roche Pharma, Reinach, Switzerland) and dissolved
freshly in phosphate-buffered saline (PBS) before use.
Cell cultures
Explants of human Tenon’s capsule were obtained from
seven patients (aged 68–93 years) at the time of cataract
surgery. None of the donors had had antiglaucomatous or
antimetabolite treatment, or ocular surgery before. All pa-
tients gave their informed consent before inclusion in
the study, which was approved by local ethics committee
and conformed with the provisions of the Declaration of
Helsiniki. The specimens were dissected and placed in
25 cm2 tissue culture flasks containing Dulbecco’s minimal
essential medium (DMEM) supplemented with L-gluta-
mine (584 mg/l), sodium pyruvate (100 mg/l), glucose
(1000 mg/l), penicillin (60 IU/ml), streptomycin (60 μg/ml)
and 10% fetal calf serum (FCS). Cultures were main-
tained in a humidified 5% CO2 incubator at 37°C. Fibro-
blasts were characterised morphologically and confluent
cultures were trypsinized, centrifuged and repassaged. The
above medium was changed twice per week. Quantified by
trypan blue dye exclusion method, viability was always
more than 95%. For the assays, third- to sixth-passage cells
were used.
Cell proliferation assay
Two experiments were performed with all seven cell lines
in triplicate. Substances were either applied to serum-stim-
ulated fibroblasts (SF) in the exponential growth phase,
or to previously quiescent serum-restimulated fibroblasts
(RF) with a beginning proliferative response. For the ex-
periments with SF and RF, 2000 and 1500 cells/well were
seeded in 96-well tissue culture plates (black/clear-bottom,
Corning Life Sciences), respectively, each well containing
200 μl of culture medium. Preliminary studies showed this
difference to be suitable for achieving similar cell densities
at the time of compound application. Fibroblasts were then
allowed to settle for 24 h in the incubator.
Growth of serum-stimulated fibroblasts (SF) Cells were
rinsed with PBS and fresh DMEM/10% FCS was added.
Vitamin E forms were diluted to the indicated concentra-
tions in above media. To mimic subconjunctival injection
and a regular oral vitamin E supplement intake in vivo,
exposure time to all vitamin E forms was set at 6 days, and
application of α-tocopherol and α-tocotrienol to the cell
cultures was repeated at days 2 and 4, respectively. In vivo,
the esters α-tocopheryl acetate and succinate are naturally
cleaved intestinally, resulting in adsorption of the active
form α-tocopherol. Repeated application was performed by
pipetting an identical amount of compounds as initially
used into the corresponding wells without changing media.
Cells treated with an equivalent amount of ethanol absolute
were also included as controls. The cumulative concentra-
tion of ethanol was less than 0.6%, which had no effect on
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proliferation and viability (data not shown). Mitomycin C
was dissolved in PBS to concentrations of 10, 100, 200 and
400 μg/ml. Due to its known acute toxicity and to mimic the
short-time intraoperative administration, SF were only ex-
posed for exactly 5 min to 100 μl/well mitomycin C so-
lution. Cells were then gently washed with PBS alone and
fed with 200 μl/well DMEM/10% FCS again. Multiple
rinsing with PBS was not performed, since a decrease in
cell density was observed in preliminary studies. PBS-
treated cultures served as control. The plates were then
incubated for 6 days at 37° C in 5% CO2 in a humidified air
atmosphere. No media was changed during this time.
Growth of serum-restimulated fibroblasts (RF) Fibroblasts
were washed with PBS 24 h after plating and incubated for
another 48–72 h with DMEM containing 0.2% FCS. As
previously described [10], this procedure induced growth
arrest on human Tenon’s capsule fibroblasts in vitro. Cell
growth was then restimulated by changing this medium to
one containing 10% FCS. Incubation with vitamin E
forms followed as described above. RF were exclusively
exposed to 100 μg/ml mitomycin C due to the almost
complete growth inhibition found in the SF experiment at
this concentration.
Morphology of SF and RF was studied daily using phase
contrast light microscopy (Leica DMIRB research micro-
scope, Leica Microsystems, Wetzlar, Germany). Photomi-
crographs were obtained with a color camera (Kappa CF15
MC, Kappa Messtechnik, Gleichen, Germany) connected
to a video printer (Sony UP-5200MDP, Sony, Schlieren,
Switzerland).
Measurement of DNA content A fluorometric assay
(CyQUANT Cell Proliferation Assay Kit, Molecular Probes,
distributed by JURO Supply, Lucerne, Switzerland) was
used to determine cell density on days 2, 4 and 6 by DNA
content quantification. Briefly, CyQuant GR dye exhibited
green fluorescence enhancement when bound to cellular
nucleic acids. Fluorescence due to dye binding to RNA
was eliminated by pretreating samples with 4 μl RNase
(DNase-free, Roche Diagnostics, Rotkreuz, Switzerland)
per ml cell lysis buffer containing 1 mM ethylenediamine-
tetraacetate (EDTA). The fluorescent dye and its solutions
were always handled light-protected. A reference standard
curve was constructed by plotting the fluorescence signal
against the DNA content of 50–10,000 human Tenon’s
capsule fibroblasts/well. The relation was strongly linear
(Pearson correlation coefficient r=0.99). On the indicated
days, plates were gently inverted and blotted onto paper
towels to remove medium from the wells. Wells were rinsed
with PBS, and dry plates were frozen at −70°C for up to 2
weeks. As stated by the manufacturer, the freezing step is
important for efficient cell lysis. In order to measure sample
fluorescence, plates were thawed, 150μl of cell lysis buffer/
EDTA/RNase was added to each well, and plates were
placed for one hour at 37° C in 5% CO2 in a humidified air
atmosphere. Next, 50 μl of 4-fold concentrated fluorescent
dye/cell lysis buffer/EDTA was added to each well. After
light-protected incubation for exactly 3 1/2 minutes, sample
fluorescence was measured with a fluorescence microplate
reader (Cytofluor 2300; Millipore, Volketswil, Switzerland)
with 485 nm excitation and 530 nm emission wave lenghts.
Cytotoxicity assay
Damaged cells release the cytosolic enzyme glucose 6-
phosphate dehydrogenase (G6PD) into the surrounding
medium. G6PD-release 24 h after incubation with vitamin
E forms or 24 h after 5-min exposure to mitomycin C was
determined fluorometrically by the Vybrant Cytotoxicity
Assay Kit (Molecular Probes, distributed by JURO Supply,
Lucerne, Switzerland). By plotting the fluorescence signal
against the G6PD medium content of 500 to 10,000 lysed
human Tenon’s capsule fibroblasts/well (reference standard
curve), a strongly linear relation was observed (Pearson
correlation coefficient r=0.98). Substances containing the
fluorescent dye were always processed light-protected. The
assay was performed with six different cell lines in trip-
licate (one cell line was lost due to contamination). In all,
7500 cells/well were seeded to optimise sensitivity of the
assay. The further procedure was identical to the prolifer-
ation assay with SF until 24 h after application of the in-
dicated compounds. Tissue culture plates (96-well) were
then gently shaken, 50 μl medium of each well was trans-
ferred to separate plates, and 50 μl/well 2-fold concentrated
resazurin/reaction mixture was added to the collected
media. After light-protected incubation for 20 minutes at
37°C, measurements were made by using the fluorescence
microplate reader with excitation at 530 nm and emission
detection at 590 nm. To determine the maximal G6PD
content, all fibroblasts in separate wells were lysed by
addition of 1 μl 100-fold concentrated cell lysis buffer/well
50 min before fluorescence measurement. Total cell lysis
was checked microscopically.
Statistical analysis
Results of the proliferation and cytotoxicity assay are
presented as mean percentage of control values and mean
percentage of total cell lysis values (mean±SD %), respec-
tively. Differences between control and compound values
were analyzed by Friedman’s test followed by the non-
parametric Dunnett’s test based on rank sum as post hoc
analysis. If only a single compound concentration was used
in the proliferation assay, results were compared with con-
trols using the Wilcoxon signed-rank test. The criterion for
statistical significance was P<0.05.
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Results
Cell proliferation and morphology
Vitamin E forms were dissolved in ethanol absolute, and
they all created small lipid droplets on the medium surface
after application. α-Tocopheryl succinatecs tiny droplets
were disappearing first within 24 h, implicating a higher
solubility in comparison with the other vitamin E forms
(their bigger droplets were visible for up to 48 h). The
results of the experiments with continiously growing and
restimulated cultures are presented in Fig. 1.
Effect of α-tocopherol
Compared with control cultures, single and multiple ap-
plication of α-tocopherol slightly stimulated growth of SF
but not RF. A mild inhibitory effect was only detected on
day 4 after twice adding 50 μM α-tocopherol to RF (80.0±
11.8%, P<0.01). Cell morphology remained identical to
control cultures during the study.
Effect of α-tocopheryl acetate
Growth of continuously growing cultures was markedly
promoted by 25–100 μM α-tocopheryl acetate. Prolifera-
tion of restimulated cultures was not affected. No degen-
erative cell changes were seen in light microscopy.
Effect of α-tocopheryl succinate
α-Tocopheryl succinate 12.5 μM demonstrated a strong
growth stimulating effect in SF cultures (maximal effect:
day 4, 157.6±56.6%). Again, proliferation of restimulated
cultures was not promoted. Higher concentrations of α-
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Fig. 1 Effects of incubation
with vitamin E forms for 6 days
or exposure to mitomycin C
for 5 min on human Tenon’s
fibroblast proliferation. Two
experiments were performed:
compounds (increasing concen-
trations upwards) were added to
serum-stimulated cells, shown at
left, and serum-restimulated
previously quiescent cells,
shown at right. To mimic regular
oral supplement intake in vivo,
application of α-tocopherol and
α-tocotrienol was further re-
peated on days 2 and 4 (con-
centrations marked with R). A
fluorometric assay determined
proliferation by DNA content
quantification on days 2, 4 and
6. Note the positive % of control
values for both experiments.
Bars with lines represent means;
-SD of seven different cell
cultures in triplicate. Significant
growth inhibiting or stimulating
effects, compared with control,
are marked with minus and plus,
respectively: ±P<0.05, −−/++
P<0.01
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tocopheryl succinate affected cell morphology and viabil-
ity. Compared to control cultures, fibroblasts exposed to
25 μM of α-tocopheryl succinate were transiently more
granulated between day 2 and 5 (Fig. 2b), accompanied by
an increased cell lysate content in the culture media. Severe
accumulation of intracytoplasmatic granules was visible
after exposure to 50 μM α-tocopheryl succinate for 24 h.
Adherent fibroblasts then retracted their long processes,
and became swollen and round shaped (Fig. 2c). The dying
cells finally released their content through ruptured plasma
membranes into the surrounding culture media. Depending
on the ability to adapt to this toxic stress and to delay cell
death, the DNA content varied strongly between the seven
different fibroblast cultures after incubation with 25 and
50 μM of α-tocopheryl succinate. On day 6, the marked
decrease of DNA content in RF cultures by 25 μM (49.5±
31.2%) and SF cultures by 50 μM α-tocopheryl succinate
(27.9±34.0%) was therefore not significant. Nevertheless,
the cytotoxic effect of 50 μM α-tocopheryl succinate was
dramatic; necrotic RF cultures showed on day 4 and 6
significantly reduced DNA contents (maximal effect: 13.9±
11.6%, P<0.01).
Effect of α-tocotrienol
Single application of 50 μM α-tocotrienol significantly
inhibited growth of both stimulated and restimulated cell
cultures. This effect was most pronounced on day 6 (61.4±
14.0% for SF and 50.7±32.8% for RF, respectively). Fur-
ther, the DNA content of RF but not of SF cultures was
strongly reduced on day 6 after repeated incubation with
20 μM α-tocotrienol (46.8±27.6%, P<0.05). By phase con-
trast microscopic observation, no degenerative cell changes
were accompanying these antiproliferative effects (Fig. 2d).
Cytotoxic effects were only observed after repeated ex-
posure to 50 μM of α-tocotrienol. After twice adding the
compound (day 4), fibroblasts showed increased cytoplas-
mic granulation, and some of them did get round shaped
(Fig. 2e). The DNA content of continuously proliferating
(41.8±24.5%) and restimulated cultures (35.5±23.5%) was
markedly decreased (P<0.01), probably partly due to an
overlap of antiproliferative and cytotoxic effects. After the
third application of 50 μM α-tocotrienol, overt necrosis as
seen during incubation with 50 μM α-tocopherol succinate
developed. Therefore, the DNA content decreased drasti-
cally on day 6 in both experiments (SF and RF).
Effect of mitomycin C
Growth of continously proliferating cultures was signifi-
cantly and strongly inhibited on all DNAmeasurement days
after 5-minute exposure to 200 and 400 μg/ml mitomycin
C, and on day 4, if treated with 100 μg/ml mitomycin C.
The antiproliferative effect of mitomycin C occurred in a
dose-dependent manner (maximal effect: 400 μg/ml, day 6,
13.8±5.9%). After 6 days, only a 17.4% growth was found
in 100 μg/ml mitomycin C treated SF cultures. RF were
therefore exclusively exposed to this antimetabolite con-
centration. Restimulated cultures were then significantly
inhibited by 100 μg/ml mitomycin C on all measurement
days (maximal effect: day 6, 34.2±16.2%).
No degenerative cell changes were seen in fibroblast
cultures exposed to mitomycin C concentrations as high as
200 μg/ml. However, 5-minute treatment with 400 μg/ml
mitomycin C resulted in a steady decrease of the absolute
DNA content over the 6 day observation period (mean
difference between day 0 and 6: −33.3%). Induction of
apoptosis by 400 μg/ml mitomycin C was assumed, as its
morphologic characteristics like nuclear and cytoplasmic
condensation, and nuclear fragmentation were observed
more often than in control cultures. In contrast to the cyto-
toxic effects of α-tocopherol succinate (50 μM) and α-
tocotrienol (repeatedly 50 μM), which affected to a varying
degree virtually all cells, most fibroblasts remaining after
Fig. 2 Phase contrast photomi-
crographs of serum-stimulated
human Tenon fibroblasts (SF)
on day 4 of the proliferation
assay. (a) control; (b) 25 μM
α-tocopheryl succinate; (c)
50 μM α-tocopheryl succinate;
(d) 50 μM α-tocotrienol; (e) R
50 μM α-tocotrienol (applica-
tion every 2nd day); (f) 400 μg/
ml mitomycin C. Arrows:
shrunken degenerated cells.
Photographs were obtained from
fibroblasts in the center of the
well. Magnification: (a), (d), (f)
×93; (b), (c), (e), ×186
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treatment with 400 μg/ml mitomycin C showed normal
morphologic features (Fig. 2f).
In general, the anti-/proliferative response to vitamin E
forms differed between continuously proliferating and re-
stimulated fibroblast cultures. RF cultures seemed to be
more susceptible to antiproliferative effects,whereas growth
stimulating effects were only observed in SF cultures. To
summarize the results of the proliferation assay, 50 μM and
repeatedly 20 μM of α-tocotrienol were the only vitamin E
forms/concentrations proving a relevant inhibitory effect
without affecting cell morphology and viability. The anti-
proliferative effect of 100–400 μg/ml mitomycin C was
stronger and earlier apparent, compared with α-tocotrienol.
Glucose 6-phosphate dehydrogenase release
Accumulation of intracytoplasmatic granules was observed
already 24 h after incubation with 50 μM α-tocopherol
succinate. To evaluate for early cytoplasmic membran rup-
ture, the G6PD release into the culture media was measured
24 h after incubation with vitamin E forms or 5-min ex-
posure to mitomycin C (Fig. 3).
Since dysmorphic cell changes were found from day 4
on after twice adding 50 μM of α-tocotrienol, 100 μM of
the compound was additionally tested to correspond with
maximum drug accumulation. This was confronted with
the effect of 100 μM α-tocopherol succinate on G6PD
release.
Of the vitamin E forms, only 50 μM (29.8±14.8% of
total cell lysis) and 100 μM of α-tocopheryl succinate
(46.0±26% of total cell lysis, P<0.01) showed increased
G6PD culture medium levels, compared to controls (13.4±
10.0% of total cell lysis). Due to the extended handling
procedure with a possible negative effect on cell viability,
G6PD culture media concentration in PBS treated wells
(control of mitomycin C) was higher than in vitamin E
control. G6PD levels of 100 and 400 μg/ml mitomycin C
were not increased in comparison with controls.
Discussion
A comparison between tocopherol and mitomycin C has
been reported previously [11]. In the present study, α-
tocotrienol and additional vitamin E forms were compared
with mitomycin C, based on their effects on proliferation,
morphology and viability of cultured human Tenon’s cap-
sule fibroblasts. The study did not account for the effects on
cell migration, attachment and contraction, collagen syn-
thesis and angiogenesis, which are further critical steps
involved in surgical bleb failure. No cultures of eyes with
increased risk of trabeculectomy failure, such as young age
or long-term use of topical anti-glaucomatous drugs, were
included in this study.
α-Tocopherol inhibits proliferation by reducing protein
kinase C activation, independent of its antioxidant proper-
ties [4, 45]. By adsorbing this lipophilic compound to FCS
[5], our group previously found a strong antiproliferative
effect on restimulated human Tenon’s capsule fibroblasts
and retinal pigment epithelium cells [10, 29]. Other authors
dissolved vitamin E in ethanol to inhibit growth of similar
cell types [38, 40]. In the present study, we used ethanol for
reasons of comparability. Instead of inhibiting prolifer-
ation, both α-tocopherol and α-tocopheryl acetate then
stimulated growth (SF cultures), or had no effect on pro-
liferation (RF cultures). The former could be explained by
the removal of lipoperoxide-induced inhibition of growth.
Higher concentrations than 100 μM were not tested, since
α-tocopherol becomes water-insoluble and precipitates in
the form of micellar aggregates in vivo. As compound and
cell type were identical in our present and previous study,
the different carrier substances (ethanol versus FCS) might
have contributed to the conflicting results to a great extent.
Lipid droplets on the culture medium surface indicated in-
homogenous distribution of the vitamin E forms previously
dissolved in ethanol. Prolonged exposure to oxygen and
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Fig. 3 Relative glucose 6-phosphate dehydrogenase (G6PD) culture
media levels 24 h after incubation with vitamin E forms and 5-min
exposure to mitomycin C. Dying cells release G6PD through rup-
tured cytoplasmic membranes. Note that 100 μM α-tocopheryl suc-
cinate and 100 μM α-tocotrienol were double the concentrations
used in the proliferation assay. Data are presented as % of total cell
lysis. Bars with lines indicate means; -SD of six different cell cul-
tures in triplicate. Significant differences, compared with control, are
marked with ** P<0.01
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heat might have inactivated a considerable amount of the
compounds prior to cellular uptake.
Together with dietary fat, all unesterized vitamin E forms
are directly absorbed in the human intestine. α-Tocopheryl
acetate and succinate are naturally cleaved intestinally,
resulting in adsorption of the active form α-tocopherol.
Only α-tocotrienol and α-tocopherol were therefore re-
peatedly applied to the cultures to mimic a regular oral
vitamin E supplement intake in vivo. However, an unpre-
dicted accumulation of vitamin E could not be fully ex-
cluded, since the relation of oxidative loss and uptake into
the cells remained unknown.
α-Tocopheryl succinate induces differentiation, DNA
synthesis arrest, or apoptosis in malignant cells, but not in
most normal cell lines [39]. Involvement of transforming
growth factor β-, Fas-, and c-Jun-NH2-terminal kinase
signaling pathways is suggested [3]. In the years 1999 and
2000, Larrosa, Pinilla and colleagues published in vitro,
animal model and histologic studies evaluating the poten-
tial application of α-tocopheryl succinate and acetate in
glaucoma surgery [21, 22, 37, 38]. Both compounds in-
jected subconjunctivally improved the outcome of glauco-
ma filtration surgery in rabbits. In our in vitro study, any
possible antiproliferative effect of α-tocopheryl succinate
was strongly overlaid by its cytotoxic effects. Increased
cytoplasmic granulation, cell swelling, and early plasma
membrane leakage strongly pointed to simple primary ne-
crosis [17]. In vivo, simple primary necrosis leads to in-
flammation of surrounding tissue. Other authors exposing
ocular cell types and tissues to comparable concentrations
of α-tocopheryl succinate (up to 100 μM) did not report
relevant cytotoxic effects [9, 38, 40, 41]. No major com-
plications were reported in a rabbit model of glaucoma
filtration surgery with adjunctive topical α-tocopheryl suc-
cinate and acetate therapy [22, 37].
In our study, α-tocotrienol was the only vitamin E form
showing a relevant inhibitory effect on both serum-stim-
ulated and -restimulated fibroblasts in the absence of
cytotoxicity. By using 50 μM or repeatedly 20 μM of α-
tocotrienol, a roughly 50% growth inhibition was achieved
after 4–6 days of incubation. Restimulated cultures were
more sensitive to this effect. We therefore conclude that α-
tocotrienol better inhibits activation of fibroblasts than
ongoing proliferation. Antiproliferative effects of higher α-
tocotrienol concentrations or γ-/δ-isoforms were not tested,
but they might be even stronger [25].
Toxic effects of α-tocotrienol were only observed from
day 4 on after twice exposing cultures to 50 μM of the
compound. In contrast to α-tocopheryl succinate, G6PD
levels after incubation with 100 μM α-tocotrienol were
not increased. Due to the different onset of degenerative
changes, the tolerability and the mechanisms of the cyto-
toxic effects seem not to be identical for both substances.
Considering the possible administration routes ofα-toco-
trienol in patients, subconjunctival injection or intraopera-
tive topical application seems favorable since sufficiently
high tissue concentrations can be assumed. Penetration of
tocotrienols through skin and of instilled α-tocopheryl
acetate into the anterior chamber and lens has been shown
in animal models [31, 47]. No toxic intraocular effects of
α-tocotrienol are known.
Vitamin E supplements to human diet are considered to
be safe. Caution is required in cases of regular aspirin
intake or in patients with vitamin K deficiency, as the risk
of bleeding is increased by vitamin E. No significant ad-
verse effects were reported in studies of long-time daily
supplementation of human individuals with palm oil toco-
trienol [46, 49, 51, 52]. No teratogenic potential is known.
However, it is remains unclear if appropriate concentra-
tions of α-tocotrienol (25–50 μM in this study) can be
achieved at the surgical site after systemic medication. α-
Tocopherol was shown to predominantly accumulate in the
retina after oral supplementation, compared with other oc-
ular tissues [2, 43]. Plasma concentrations of α-tocotrienol
only increased from less than 1 μM to approximately 8 μM
in humans supplemented with a palm oil concentrate [52].
However, accumulation of α-tocotrienol in many solid or-
gans/tissues is well known. α-Tocotrienol concentrations
in the skin and adipose tissue can be tenfold to those in the
plasma [12, 13, 34].
Induction of apoptotic cell death in human Tenon’s cap-
sule fibroblasts after 5-min exposure to 400 μg/ml mito-
mycin C has been described by Crowston and colleagues
[6, 7]. After 6 days, 27% of the fibroblasts were reported
to exhibit morphologic characteristics of apoptosis [6].
Under very similar conditions, we detected a comparable
cell content decrease by 33% and morphologic alterations
such as nuclear and cytoplasmic condensation, indicating
an apoptotic effect of 400 μg/ml mitomycin C. It should
be noted that the methods applied prove cell death, but not
its mechanism.
Apoptosis has been shown to be physiologically involved
in scar formation [8]. As apoptosis does in general not
provoke an inflammatory reponse in vivo [17], death of
fibrolasts and inflammatory cells by apoptosis should be an
acceptable event in the postoperative period, leading to
reduction of scar tissue. However, complications such as
bleb leak and infection may occur if the bleb tissue is too
extensively devitalized.
Comparing α-tocotrienol and mitomycin C, fibroblast
proliferation was earlier and stronger inhibited after 5-min
exposure to the antimetabolite. Almost complete growth
inhibition of SF cultures was achieved by using 100 μg/ml
mitomycin C. Furthermore, mitomycin C induced growth
arrest is irreversible based on its DNA alkylating proper-
ties. As α-tocotrienol regulates the activity of cytosolic
enzymes, its antiproliferative effect is not likely to last for
a long time after medication is discontinued. However,
mitomycin C induced toxicity to ocular structures is well
known. Alternative drugs with a reversible antiproliferative
effect may be advantageous in wound healing situations
where the healing stimulus is maximal only during a short
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period that can be covered by treatment. Due to the different
antiproliferative mechanisms, a synergistic effect of α-
tocotrienol and mitomycin C is further conceivable, po-
tentially allowing lower mitomycin C concentrations and
shorter exposure-time to increase drug safety. Our findings
suggest that α-tocotrienol deserves further evaluation in
animal model studies to clarify its impact on the outcome of
filtering procedures.
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